Evidence map›Paper›PMID 25996526›Full record

ArticleGenes and immunity2015

Trichuris suis soluble products induce Rab7b expression and limit TLR4 responses in human dendritic cells.

E J Klaver, T C T M van der Pouw Kraan, L C Laan, H Kringel, R D Cummings, G Bouma, G Kraal, I van Die

Open access · bronzeAbstract read
In one paragraph

Article in Genes and immunity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Mining Helminths for Novel Therapeutics.Trends in molecular medicine · 2021
    Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Clinical Use ofFrontiers in immunology · 2020
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

E J KlaverDepartment of Molecular Cell Biology and Immunology, VU University Medical Center, Amsterdam, The Netherlands.
T C T M van der Pouw KraanDepartment of Molecular Cell Biology and Immunology, VU University Medical Center, Amsterdam, The Netherlands.
L C LaanDepartment of Molecular Cell Biology and Immunology, VU University Medical Center, Amsterdam, The Netherlands.
H KringelSection for Parasitology, Health and Development, Department of Veterinary Disease Biology, University of Copenhagen, Copenhagen, Denmark.
R D CummingsDepartment of Biochemistry, Emory University School of Medicine, Atlanta, GA, USA.
G BoumaDepartment of Gastroenterology, VU University Medical Center, Amsterdam, The Netherlands.
G KraalDepartment of Molecular Cell Biology and Immunology, VU University Medical Center, Amsterdam, The Netherlands.
I van DieDepartment of Molecular Cell Biology and Immunology, VU University Medical Center, Amsterdam, The Netherlands.
Amsterdam UMC Location Vrije Universiteit Amsterdam · NLEmory University · USUniversity of Copenhagen · DK

Funding

Modulation of Inflammatory Responses by Helminth GlycansR01AI101982 · NIAID · EMORY UNIVERSITY · PI CUMMINGS, RICHARD D · 2013 to 2017
$2.4M
NIAID NIH HHS AI101982NIAID NIH HHS R01 AI101982
6 · The paper itself

Abstract

Inflammatory immune disorders such as inflammatory bowel disease and multiple sclerosis are major health problems. Currently, the intestinal whipworm Trichuris suis is being explored in clinical trials to reduce inflammation in these diseases; however, the mechanisms by which the parasite affects the host immune system are not known. Here we determined the effects of T. suis soluble products (SPs) on Toll-like receptor-4 (TLR4)-stimulated human dendritic cells (DCs) using Illumina bead chip gene arrays. Pathway analysis of lipopolysaccharide-stimulated DCs with or without T. suis treatment showed that co-stimulation with T. suis SPs resulted in a downregulation of both the myeloid differentiation primary response gene 88-dependent and the TIR-domain-containing adaptor-inducing interferon-β-dependent signalling pathways triggered by TLR4. These data were verified using quantitative real-time PCR of several key genes within these pathways and/or defining their protein levels. In addition, T. suis SPs induce Rab7b, a negative regulator of TLR4 signalling that interferes with its trafficking, which coincided with a reduced surface expression of TLR4. These data indicate that the mechanism by which T. suis SPs reduce inflammatory responses is through suppression of both TLR4 signalling and surface expression on DCs.

Indexed as

AnimalsDendritic CellsDown-RegulationHumansInflammationLipopolysaccharidesrab7 GTP-Binding Proteinsrab GTP-Binding ProteinsReal-Time Polymerase Chain ReactionSignal TransductionToll-Like Receptor 4TranscriptomeTrichurisLipopolysaccharidesrab7 GTP-Binding Proteinsrab GTP-Binding ProteinsTLR4 protein, humanToll-Like Receptor 4

Identifiers

PMID25996526
PMCPMC6382076
OpenAlexW1547139242

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.